Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 75

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Unfolding, Aggregation, and Amyloid Formation by the Tetramerization Domain from Mutant p53 Associated with Lung Cancer

Higashimoto, Yuichiro, Asanomi, Yuya, Takakusagi, Satoru, Lewis, Marc S., Uosaki, Kohei, Durell, Stewart R., Anderson, Carl W., Appella, Ettore, Sakaguchi, Kazuyasu·2006·Biochemistry
DOI 10.1021/bi051192j
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/bi051192j

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 60

  1. Levine, A. J. (1997) p53, the cellular gatekeeper for growth and division,Cell 88, 323−331. · DOI · Paper page
  2. Vousden K. H., 2002, Nat. Rev. Cancer, 2, 10.1038/nrc864 · DOI · Paper page
  3. Pietenpol J. A., 1998, W. S., Kinzler, K. W., and Vogelstein, B. (1994) Sequence-specific transcriptional activation is essential for growth suppression by, 53
  4. Lee, W., Harvey, T. S., Yin, Y., Yau, P., Litchfield, D., and Arrowsmith, C. H. (1994) Solution structure of the tetrameric minimum transforming domain of p53,Nat. Struct. Biol. 1, 877−890. · DOI · Paper page
  5. Clore, G. M., Ernst, J., Clubb, R., Omichinski, J. G., Kennedy, W. M. P., Sakaguchi, K., Appella, E., and Gronenborn, A. M. (1995) Refined solution structure of the oligomerization domain of the tumour suppressor p53,Nat. Struct. Biol. 2, 321−333. · DOI · Paper page
  6. Jeffrey, P. D., Gorina, S., and Pavletich, N. P. (1995) Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms,Science 267, 1498−1502. · DOI · Paper page
  7. Mittl P. R. E., 1998, Biol. Crystallogr., 54, 89
  8. Hollstein M., 1991, Science, 253, 53, 10.1126/science.1905840 · DOI · Paper page
  9. Olivier M., 2002, Hum. Mutat. 19, 607−614.
  10. Fujita T., 1999, Int. J. Oncol., 15
  11. Hainaut, P., and Pfeifer, G. P. (2001) Patterns of p53 G→T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke,Carcinogenesis 22, 367−374. · DOI · Paper page
  12. Dumoulin M., 2004, Biochimie 86, 589−600.
  13. Stefani M., 2003, J. Mol. Med., 81, 10.1007/s00109-003-0464-5 · DOI · Paper page
  14. Takahashi Y., 1999, Bioorg. Med. Chem., 7, 185, 10.1016/S0968-0896(98)00236-3 · doi:10.1016/s0968-0896(98)00236-3
  15. Sipe J. D., 2000, J. Struct. Biol., 130, 98
  16. Dobson C. M., 2003, Nature 426, 884−890.
  17. Serpell L. C., 2000, Biochim. Biophys. Acta, 1502, 30
  18. Dobson C. M., 2001, Philos. Trans. R. Soc. London, Ser. B, 356
  19. Ohnishi S., 2004, Cell. Mol. Life Sci. 61, 511−524.
  20. Johansson J., 2003, Wkly. 133, 275−282.
  21. Thirumalai D., 2003, Curr. Opin. Struct. Biol. 13, 146−159.
  22. Zerovnik E., 2002, Eur. J. Biochem., 269
  23. Rochet J. C., 2000, Curr. Opin. Struct. Biol., 10, 68, 10.1016/S0959-440X(99)00049-4 · DOI · Paper page
  24. Chiti F., 2003, Nature 424, 805−808.
  25. Gill S. C., 1989, Anal. Biochem. 182, 319−326.
  26. Sreerema N., 1993, Anal. Biochem., 209, 44
  27. Klunk W. E., 1989, J. Histochem. Cytochem., 7
  28. Levine H., 1995, Amyloid, 2, 6, 10.3109/13506129509031881 · DOI · Paper page
  29. Sakamoto, H., Lewis, M. S., Kodama, H., Appella, E., and Sakaguchi, K. (1994) Specific sequences from the carboxyl terminus of human p53 gene product form anti-parallel tetramers in solution,Proc. Natl. Acad. Sci. U.S.A. 91, 8974−8978. · DOI · Paper page
  30. Sakaguchi, K., Sakamoto, H., Lewis, M. S., Anderson, C. W., Erickson, J. W., Appella, E., and Xie, D. (1997) Phosphorylation of serine 392 stabilizes the tetramer formation of tumor suppressor protein p53,Biochemistry 36, 10117−10124. · DOI · Paper page
  31. Berman H. M., 2000, Nucleic Acids Res. 28, 235−242.
  32. Brooks B. R., 1983, J. Comput. Chem., 4, 10.1002/jcc.540040211 · DOI · Paper page
  33. MacKerell A. D., Jr., 1998, J. Phys. Chem. B, 102
  34. Chou P. Y., 1974, Biochemistry 13, 222−245.
  35. Rost B., 2001, J. Struct. Biol., 134, 10.1006/jsbi.2001.4336 · DOI · Paper page
  36. Rost B., 2004, Nucleic Acids Res. 32, W321−W326.
  37. Yoon S., 2004, Protein Sci. 13, 2149−2160.
  38. Yoon S., 2005, Proteins 60, 110−117.
  39. Lawless M. K., 1996, Biochemistry 35, 13697−13708.
  40. Bothner B., 2001, J. Mol. Biol., 314, 10.1006/jmbi.2001.5110 · DOI
  41. Buck M., 1998, Q. Rev. Biophys., 31, 10.1017/S003358359800345X · DOI · Paper page
  42. Lau S. Y. M., 1984, J. Biol. Chem., 259
  43. Lovell S. C., 2003, Proteins 50, 437−450.
  44. Kallberg Y., 2001, J. Biol. Chem., 276, 10.1074/jbc.M010402200 · DOI · Paper page
  45. Ishimaru, D., Andrade, L. R., Teixeira, L. S. P., Quesado, P. A., Maiolino, L. M., Lopez, P. M., Cordeiro, Y., Costa, L. T., Heckl, W. M., Weissmüller, G., Foguel, D., and Silva, J. L. (2003) Fibrillar aggregates of the tumor suppressor p53 core domain,Biochemistry 42, 9022−9027. · DOI · Paper page
  46. Friedler A., 2003, J. Biol. Chem., 278, 10.1074/jbc.M302458200 · DOI · Paper page
  47. Lee A. S., 2003, J. Mol. Biol., 327
  48. Davison, T. S., Yin, P., Nie, E., Kay, C., and Arrowsmith, C. H. (1998) Characterization of the oligomerization defects of two p53 mutants found in families with Li-Fraumeni and Li-Fraumeni-like syndrome,Oncogene 17, 651−656. · DOI
  49. Ribeiro, R. C., Sandrini, F., Figueiredo, B., Zambetti, G. P., Michalkiewicz, E., Lafferty, A. R., DeLacerda, L., Rabin, M., Cadwell, C., Sampaio, G., Cat, I., Stratakis, C. A., and Sandrini, R. (2001) An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma,Proc. Natl. Acad. Sci. U.S.A. 98, 9330−9335. · DOI · Paper page
  50. Mateu M. G., 1998, EMBO J., 17, 10.1093/emboj/17.10.2748 · DOI
  51. Takahashi Y., 2000, Structure 8, 915−925.
  52. Kirkitadze M. D., 2001, J. Mol. Biol., 312, 10.1006/jmbi.2001.4970 · DOI · Paper page
  53. Fezoui Y., 2002, J. Biol. Chem., 277, 10.1074/jbc.M204168200 · DOI · Paper page
  54. Modler A. J., 2003, J. Mol. Biol., 325, 10.1016/S0022-2836(02)01175-0 · DOI · Paper page
  55. Gorman P. M., 2003, J. Mol. Biol., 325, 10.1016/S0022-2836(02)01279-2 · DOI
  56. Stucki B., 1999, Thromb. Haemostasis 81, 268−274.
  57. Panegyres P. K., 2001, Arch. Neurol. 58
  58. Atz J., 2000, J. Cell Biochem., 76
  59. Lomax, M. E., Barnes, D. M., Hupp, T. R., Picksley, S. M., and Camplejohn, R. S. (1998) Characterization of p53 oligomerization domain mutations isolated from Li-Fraumeni and Li-Fraumeni like family members,Oncogene17, 643−649. · DOI
  60. Abbreviations CD, circular dichroism

Cited by

See all 75

Metadata

Authors
Higashimoto, Y., Asanomi, Y., Takakusagi, S., Lewis, M. S., Uosaki, K., Durell, S. R., Anderson, C. W., Appella, E., & Sakaguchi, K.
Affiliations
Department of Medical Biochemistry, Kurume University School of Medicine, Kurume 830-0011, Japan, and Biological Chemistry and Physical Chemistry, Division of Chemistry, Graduate School of Science, Hokkaido University, Sapporo 060-0810, Japan, Molecular Interactions Resource, Division of Bioengineering and Physical Science, Office of Research Services, Office of Director, and Center for Cancer Research Nanobiology Program, National Institutes of Health, Bethesda, Maryland 20892, Biology Department,...
Venue
Biochemistry
Publisher
American Chemical Society (ACS)
Published
2006-01-24
Volume
45
Issue
6
Pages
1608-1619
ISSN
  • 0006-2960
  • 1520-4995
DOI
10.1021/bi051192j
Cited by
75
References
3
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.